Search research articles
Contact Us
Filters
Showing results (271-280 of 301) with videos related to
Page
of 31
Sort By:
The Cochrane Database of Systematic Reviews
|
July 20, 2007
WITHDRAWN: Calcium supplementation on bone loss in postmenopausal women
B Shea, G Wells, A Cranney, et al.
The Cochrane Database of Systematic Reviews
|
October 30, 2003
Calcium supplementation on bone loss in postmenopausal women
B Shea, G Wells, A Cranney, et al.
The Cochrane Database of Systematic Reviews
|
February 20, 2004
Calcium supplementation on bone loss in postmenopausal women
B Shea, G Wells, A Cranney, et al.
Arthritis and Rheumatism
|
October 23, 1997
Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group
C M Stein, T Pincus, D Yocum, et al.
Archives of Internal Medicine
|
January 1, 1990
Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires
P Tugwell, C Bombardier, W W Buchanan, et al.
The Journal of Rheumatology
|
March 1, 1988
An experiment in reducing interobserver variability of the examination for joint tenderness
A V Klinkhoff, N Bellamy, C Bombardier, et al.
Arthritis and Rheumatism
|
February 1, 1990
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee
F Wolfe, H A Smythe, M B Yunus, et al.
The Journal of Rheumatology
|
June 1, 1993
Modelling the population health impact of musculoskeletal diseases: arthritis
D L Reynolds, G W Torrance, E M Badley, et al.
Lancet (London, England)
|
May 5, 1990
Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis
P Tugwell, C Bombardier, M Gent, et al.
The Journal of Rheumatology. Supplement
|
September 1, 1994
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials
M Boers, P Tugwell, D T Felson, et al.
Page
of 31
Search research articles
Search
Showing results (271-280 of 301) with videos related to
Sort By:
Page
of 31
The Cochrane Database of Systematic Reviews
|
July 20, 2007
WITHDRAWN: Calcium supplementation on bone loss in postmenopausal women
B Shea, G Wells, A Cranney, et al.
The Cochrane Database of Systematic Reviews
|
October 30, 2003
Calcium supplementation on bone loss in postmenopausal women
B Shea, G Wells, A Cranney, et al.
The Cochrane Database of Systematic Reviews
|
February 20, 2004
Calcium supplementation on bone loss in postmenopausal women
B Shea, G Wells, A Cranney, et al.
Arthritis and Rheumatism
|
October 23, 1997
Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group
C M Stein, T Pincus, D Yocum, et al.
Archives of Internal Medicine
|
January 1, 1990
Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires
P Tugwell, C Bombardier, W W Buchanan, et al.
The Journal of Rheumatology
|
March 1, 1988
An experiment in reducing interobserver variability of the examination for joint tenderness
A V Klinkhoff, N Bellamy, C Bombardier, et al.
Arthritis and Rheumatism
|
February 1, 1990
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee
F Wolfe, H A Smythe, M B Yunus, et al.
The Journal of Rheumatology
|
June 1, 1993
Modelling the population health impact of musculoskeletal diseases: arthritis
D L Reynolds, G W Torrance, E M Badley, et al.
Lancet (London, England)
|
May 5, 1990
Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis
P Tugwell, C Bombardier, M Gent, et al.
The Journal of Rheumatology. Supplement
|
September 1, 1994
World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials
M Boers, P Tugwell, D T Felson, et al.
Page
of 31